JPRN-UMIN000042023已完成2 期
A Clinical Study of SHP674 in Patients With Newly Diagnosed, Untreated Acute Lymphoblastic Leukemia - A Clinical Study of SHP674 in Patients With Newly Diagnosed, Untreated Acute Lymphoblastic Leukemia
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1years-old 至 21years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Mature B-cell ALL ; Philadelphia chromosome-positive (Ph+) or BCR-ABL1-positive ALL. Preexisting known coagulopathy. History of pancreatitis. Continuous use of corticosteroids. Prior treatment or possible prior treatment with an L-asparaginase preparation. History of sensitivity to polyethylene glycol (PEG) or PEG-based drugs. Pregnant
研究者
相似试验
已完成
2 期
A Clinical Study of SHP674 (Pegaspargase) in Participants With Newly Diagnosed, Untreated Acute Lymphoblastic LeukemiaAcute Lymphoblastic LeukemiaNCT04067518Institut de Recherches Internationales Servier28
尚未招募
2 期
A study of HT-6184 in subjects with Myelodysplastic Syndrome (MDS) and Symptomatic Anemia.CTRI/2023/11/059758Halia Therapeutics
未知
2 期
A Phase 2/3 Study of S-524101 in the Patients with Perennial Allergic RhinitisAllergic rhinitisJPRN-jRCT2080221872SHIONOGI & CO., LTD.
已完成
2 期
PhaseII Study of SI-657 in Patients with Enthesopathy (Lateral Epicondylitis)Enthesopathy (Lateral Epicondylitis)JPRN-UMIN000008218KAKEN PHARMACEUTICAL CO., LTD/SEIKAGAKU CORPORATIO40
未知
3 期
A Phase 3 study of S-474474 in patients with essential hypertensioHypertensionJPRN-jRCT2080221505SHIONOGI & CO., LTD.